Meeting
2021 ASCO Quality Care Symposium
Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS).
Authors
Arjun Gupta
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Arjun Gupta, Leonce Nshuti, Udhayvir Singh Grewal, Ramy Sedhom, Helen Parsons, Anne Hudson Blaes, Beth A. Virnig, Maryam B. Lustberg, Ishwaria Mohan Subbiah, Ryan David Nipp, Sydney M. Dy, Stacie Dusetzina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 55)
DOI
10.1200/JCO.2020.39.28_suppl.55
Abstract #
55
Poster Bd #
B21
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Medications to manage cancer-associated anorexia/cachexia syndrome (CACS) in patients with advanced gastrointestinal (GI) cancer.
First Author: Nivedita Arora
Poster
2023 ASCO Quality Care Symposium
Potential out-of-pocket savings from hematology/oncology drugs for commercially insured patients via Mark Cuban Cost Plus Drug Company.
First Author: Jenny Jing Xiang
Poster
2023 ASCO Quality Care Symposium
The high cost of supplements, complementary therapy, and alternative medicine in patients with breast cancer.
First Author: Kaitlyn Lapen
Poster
2023 ASCO Annual Meeting
The role of private insurance characteristics in the out-of-pocket costs of patients with multiple myeloma.
First Author: Hamlet Gasoyan